Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Blood-brain Barrier Permeability in Alzheimer's Disease

Authors not listed

Maastricht University Medical Center · 2012

Abstract

The main aim of the present study is to improve our understanding of the role of blood-brain barrier function in dementia of the Alzheimer's type. The investigators hypothesize that microvascular dysfunction - more specifically "cerebral perfusion and blood-brain barrier leakage" - is a determinant of cognitive decline and cortical atrophy in Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2012). Blood-brain Barrier Permeability in Alzheimer's Disease. <em>Maastricht University Medical Center</em>. https://clinicaltrials.gov/study/NCT01574456
Vancouver
Anonymous. Blood-brain Barrier Permeability in Alzheimer's Disease. Maastricht University Medical Center. 2012.
BibTeX
@misc{anon2012Bloodb, title = {Blood-brain Barrier Permeability in Alzheimer's Disease}, author = {Anonymous}, journal = {Maastricht University Medical Center}, year = {2012}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings